Mutations Position Table

PSEN1 L166 Mutations

Tools

Back to the Top
Mutation Pathogenicity DNA Change Expected RNA | Protein Consequence Coding/Non-Coding Genomic Region Neuropathology Biological Effect Primary
Papers
L166P
AD : Pathogenic, ALS-FTD : Not Classified Substitution Substitution | Missense Coding Exon 6

In one individual, numerous Aβ-positive neuritic and cotton-wool plaques throughout the cerebral cortex; abundant Aβ-positive amyloid cores in the cerebellar cortex. In another, robust amyloid pathology in the striatum and cerebellum, and asymmetric tau pathology in the primary sensorimotor cortex contralateral to the side most affected by spasticity.

Decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 and increased Aβ42/Aβ40. Increased Aβ42 and Aβ43; endosomal accumulation of APP β-CTF. Also, interfered with wild-type PSEN1 activity, reduced GLT-1 interaction, inhibited calcium leak in the ER, affected ApoE secretion, altered PSEN1 subcellular localization. Stalled γ-secretase-substrate complex tied to synaptic loss.

Moehlmann et al., 2002
L166H
AD : Not Classified Substitution Substitution | Missense Coding Exon 6

Unknown; MRI showed marked hippocampal atrophy and cortical atrophy, especially in the insula and the peri-insular temporal lobe. SPECT imaging showed bilateral hypometabolism in the parietal and frontal lobes.

Unknown, but multiple in silico algorithms predicted a damaging effect.

Pantieri et al., 2005
L166R
AD : Pathogenic Substitution Substitution | Missense Coding Exon 6

Unknown; MRI in the proband showed cortical atrophy; PET showed parietal hypoperfusion.

Unknown, but multiple in silico algorithms predicted a damaging effect.

Ezquerra et al., 2000
L166del
AD : Not Classified Deletion Deletion | Deletion Coding Exon 6

Unknown; MRI showed generalized, symmetrical cerebral atrophy, which was most prominent in the medial temporal lobes.

Unknown.

Knight et al., 2007
L166V
AD : Pathogenic Substitution Substitution | Missense Coding Exon 6

SPECT imaging performed four years after symptom onset showed temporoparietal hypoperfusion. Postmortem evaluation revealed neuropathology consistent with AD, including advanced plaques and tangles (CERAD C, Braak stage VI).

Unknown; predicted damaging in silico by multiple algorithms.

Sassi et al., 2014

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.